Geneoscopy Tech Stack

FDA-approved RNA biomarker tests for colorectal cancer and GI disease screening

Biotechnology Research St. Louis, MO 51–200 employees Founded 2015 Privately Held

Geneoscopy develops proprietary stool-derived RNA diagnostic tests for gastrointestinal screening and disease management. The hiring mix—skewed toward healthcare, manufacturing, and marketing roles with limited engineering—reflects a commercialization-stage life sciences company scaling lab operations and distribution rather than platform development. Active projects center on ColoSense™ market expansion, reimbursement navigation, and supply-chain implementation, while pain points highlight the operational reality of diagnostic companies: GMP compliance, coverage denials, and payment friction.

Tech Stack 22 technologies

Core StackCanva Adobe Creative Cloud SAP Oracle NetSuite Smartsheet AWS Kubernetes Helm Docker GitLab CI/CD GitLab Jira Sage Intacct ddPCR Azure GCP AWS EKS Karpenter AWS ECR Flux LIMS

What Geneoscopy Is Building

◆Challenges

Lost account recovery
Insulating existing business from competitive threats
Maintaining gmp compliance
Ensuring production efficiency
Continuous improvement of quality management system
Overturning medicaid coverage denials
Ensuring timely payment after coverage
Identifying reimbursement friction points
Scaling and reliability needs
Complex infrastructure problems

▲Active Projects

Implementation of supply chain technologies
Commercialization and brand evolution of colosense™
Website management
Territory-specific business plans for key accounts
Marketing campaign development and execution
Quarterly plan of action meetings
Press releases
New product launch readiness
Lab billing revenue recognition
Coverage policy submissions to state medicaid ffs programs

Hiring Activity

Accelerating15 roles · 10 in 30d

Department

Healthcare

Manufacturing

Marketing

Engineering

Finance

Logistics

Ops

Quality

Seniority

Junior

Manager

Mid

Senior

Director

Company intelligence

Find more companies like Geneoscopy by tech stack, pain points and active projects

Get started free

About Geneoscopy

Geneoscopy is a St. Louis-based diagnostics company founded in 2015, focused on gastrointestinal health screening and disease monitoring. The company's core product is ColoSense™, an FDA-approved test that detects colorectal cancer and advanced adenomas in average-risk adults over 45 using a proprietary RNA biomarker platform extracted from stool samples. Beyond colorectal screening, Geneoscopy partners with academic institutions and pharmaceutical companies to develop companion diagnostics for treatment selection and therapy monitoring in other GI disease areas. The company operates a 51–200 person organization primarily in the United States, with infrastructure spanning lab operations, manufacturing, commercial sales, and reimbursement management.

HeadquartersSt. Louis, MO

Company Size51–200 employees

Founded2015

Hiring MarketsUnited States

Frequently Asked Questions

What is Geneoscopy's main product?

ColoSense™, an FDA-approved diagnostic test that uses proprietary stool-derived RNA biomarkers to screen for colorectal cancer and advanced adenomas in patients over 45.

Where is Geneoscopy headquartered?

St. Louis, Missouri. The company was founded in 2015 and is privately held with 51–200 employees, all hiring in the United States.

How this profile is built

Geneoscopy's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.